Fort Washington Investment Advisors Inc Regeneron Pharmaceuticals, Inc. Transaction History

Fort Washington Investment Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	SELL	$351.14 - $408.51 $250,011 - $290,859	-712 Closed	0 $0
Q2 2018 Jul 27, 2018	SELL	$284.6 - $344.99 $774,396 - $938,717	-2,721 Reduced 79.26%	712 $246,000
Q1 2018 May 02, 2018	SELL	$315.82 - $393.78 $140,539 - $175,232	-445 Reduced 11.47%	3,433 $1.18 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $12,552 - $16,448	35 Added 0.91%	3,878 $1.46 Million
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $62,550 - $73,080	-145 Reduced 3.64%	3,843 $1.72 Million
Q2 2017 Aug 10, 2017	BUY	N/A	3,988	3,988 $1.96 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.